Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients
Clinical trial NCT03971383 · UNKNOWN
Trial details
- NCT number
- NCT03971383
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-10
- Primary completion
- 2020-10-31
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.